Star Imaging And Path Lab Ltd (STARIMAGIN)

Loading page…

Star Imaging And Path Lab Ltd (STARIMAGIN) · mywealthgrid

About

Star Imaging And Path Lab Ltd is a healthcare services provider with a market cap of ₹169.35 Cr and 71.92% promoter ownership. As a small-cap player in a sector typically fragmented across regional operators, it operates in healthcare services.

Face value: ₹10

Market cap

₹130 Cr

P/E

4,321.6×

P/B

—

Dividend yield

ROE

—

ROCE

—

Debt / equity

—

OPM

37.5%

EPS (TTM)

₹0.0

Book value

—

52-week high

—

52-week low

—

Key insights

Company research notes and source-linked reviews

Key risks

Profitability crisis: ROE of 0.08% and PE n/a indicate the company is unprofitable — verify revenue base, cost structure, and timeline to break-even
Institutional investor exodus: FII fell 55% (1.37% to 0.61%) and DII fell 39% (9.33% to 5.73%) in six months — verify the reason for investor exits
Debt service pressure: D/E of 0.69 with minimal earnings (ROE 0.08%) threatens refinancing and cash generation — verify debt maturity and interest coverage
Liquidity and volatility: 52-week price range of ₹46.29–₹147.9 (>2x) suggests thin trading or high uncertainty — verify daily volumes and bid-ask spreads

Generated analysis · source review pending

Growth drivers

Healthcare services typically generate recurring revenue when patient relationships are established — verify company's patient base, retention rates, and revenue per center
Healthcare spending and diagnostic adoption continue to grow in India — verify company's geographic penetration, market share, and growth rate
Small market cap (₹169.35 Cr) with moderate debt (D/E 0.69) positions for rapid deleveraging once EBITDA-positive — verify path to profitability and cash burn rate

Generated analysis · source review pending

274 historical price candles were omitted because the exchange source has not been verified.

₹74.5-1%1Y

Quick read

rule-based

Pros

+Healthy operating margin of 37.5%
+Profit CAGR of 221.5% over the last 3 years
+Comfortable interest coverage of 14.3×
+High promoter holding of 71.9% with no pledge

Cons

−Low return on equity of 1.1% (3-yr avg)
−Expensive at 4321.6× trailing earnings

Research score

Structured signal from quality, growth, valuation and momentum.

59/100

Business quality: 98
Growth: 80
Valuation

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Screen this industry Compare top 5 side-by-side

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Dr. Lal Path Labs Ltd.LALPATHLABLALPATHLAB	₹33,605 Cr	₹33,605 Cr	₹2,891 Cr	₹838 Cr	28.3%	₹542 Cr	18.5%	28.8%	21.6%	-79
Vijaya Diagnostic Centre LimitedVIJAYAVIJAYA	₹14,694 Cr	₹14,694 Cr	₹857 Cr	₹362 Cr	41.4%	₹187 Cr	21.3%	21.3%	19.7%	-117
Metropolis Healthcare LimitedMETROPOLISMETROPOLIS	₹11,151 Cr	₹11,169 Cr	₹1,710 Cr	₹422 Cr	24.4%	₹202 Cr	11.6%	17.3%	13.4%	-57
Thyrocare Technologies LimitedTHYROCARETHYROCARE	₹8,495 Cr	₹8,495 Cr	₹876 Cr	₹282 Cr	31.6%	₹176 Cr	19.6%	36.5%	28.8%	4
Nephrocare Health Services LimitedNEPHROPLUSNEPHROPLUS	₹6,509 Cr	₹6,589 Cr	₹999 Cr	₹227 Cr	22.7%	₹77 Cr	7.7%	17.1%	9.1%	-61
Suraksha Diagnostic LimitedSURAKSHASURAKSHA	₹1,824 Cr	₹1,826 Cr	₹325 Cr	₹102 Cr	30.7%	₹36 Cr	10.1%	16.8%	14.1%	-101
Krsnaa Diagnostics LimitedKRSNAAKRSNAA	₹1,798 Cr	₹2,332 Cr	₹815 Cr	₹218 Cr	27.4%	₹97 Cr	13.1%	13.1%	10.9%	65
3b Blackbio Dx Limited3BBLACKBIO3BBLACKBIO	₹1,416 Cr	₹1,417 Cr	₹96 Cr	₹50 Cr	52%	₹163 Cr	49.4%	25.3%	19.4%	235
One Global Service Provider LtdONEGLOBALONEGLOBAL	₹1,025 Cr	₹1,025 Cr	₹6 Cr	₹1 Cr	22.2%	₹1 Cr	17.3%	17.6%	19.5%	—
Health X Platform LimitedHEALTHXHEALTHX	₹868 Cr	₹890 Cr	₹1,468 Cr	₹-67 Cr	-4%	₹-20 Cr	-0.1%	—	0.2%	—
Gaudium Ivf And Women Health LimitedGAUDIUMIVFGAUDIUMIVF	₹797 Cr	₹820 Cr	₹104 Cr	₹38 Cr	36.1%	₹24 Cr	23.4%	23.1%	16.1%	92
Aspira Pathlab & Diagnostics LtdASPIRAASPIRA	₹135 Cr	₹136 Cr	₹22 Cr	₹4 Cr	16%	₹2 Cr	9.2%	17.5%	18.1%	16

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Consolidated Standalone

Consolidated figures · ₹ crore

₹ Cr	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	59	79	84	89
COGS	—	—	—	6
Gross profit	—	—	—	83
	22	28	24	50
	—	—	—	33
OPM %	—	—	—	37.5%
Depreciation	3	5	5	6
Interest	2	2	3	2
	0	1	0	1
Profit before tax	1	16	21	26
Tax	0	4	5	7
Tax %	34.8%	22.8%	25.6%	26.7%
	1	12	16	19
PAT margin %	1%	15.8%	19.1%	21.8%
EPS (₹)	0.4	9.2	11.8	11.1

₹ Cr	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	2	2	14	—
Reserves	17	30	34	—
	27	31	33	—
	16	20	18	154
Total equity & liabilities	61	82	98	154
	13	22	21	25
CWIP	6	0	0	—
Investments	0	0	0	0
	42	60	77	128
Total assets	61	82	98	154

₹ Cr	Mar 2026
	23
	-13
	36
Net cash flow	46
Free cash flow	13
CFO / Operating profit %	70.4%

Compounded sales growth

7 years: —
5 years: —
3 years: 15%
1 year: 6%

Compounded profit growth

7 years: —
5 years: —
3 years: 222%
1 year: 21%

Return on equity

7 years: —
5 years: —
3 years: 26%
Last year: 34%

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Consolidated Standalone

Consolidated figures

Ratio	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	—	—	—	93.6%
EBITDA margin %	—	—	—	37.5%
EBIT margin %	—	—	—	30.8%
PAT margin %	1%	15.8%	19.1%	21.8%
Working capital
Receivable days	110	151	222	—
Inventory days	10	7	4	24
Payable days	—	—	—	—
NWC days	—	—	—	—
Leverage
Current ratio	1.01	1.63	1.97	4
Debt to EBITDA	—	—	—	—
Debt to equity	1.4	0.98	0.69	—
Interest coverage	-1.8	-1.8	-1.9	14.3
Asset turnover	0.96	0.96	0.85	0.58
Return ratios
Return on assets %	0.9%	15.2%	16.3%	12.6%
Return on capital employed %	-9%	-9.6%	-8.3%	29.9%
Return on equity %	3.1%	39.7%	33.8%	—

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Jun 2025	Sep 2025	Mar 2026
	71.92%	71.92%	71.92%
	1.18%	1.37%	0.61%
	11.44%	9.33%	5.73%
	0%	0%	0.41%
	15.46%	17.38%	21.33%
No. of shareholders	1,025	779	773

Promoter holding up 0 percentage points since Jun 2025.

Pawan GuptaManaging Director
Chhaya GuptaExecutive Director
Neelam RatraExecutive Director
Sameer SoodNon- Executive Director
Vimal GuptaIndependent Director
Yogesh Kumar VirmaniIndependent Director
Dikshant NagpalIndependent Director
Md Shadab KhanCompany Secretary & Compliance Officer

Current officeholders as filed with BSE. A person holding two offices is listed once per office.

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

No fund holdings on record

No scheme among the 32 fund houses on record reported a position in Star Imaging And Path Lab Ltd. Portfolios are published monthly by each AMC; coverage is still partial.

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

No events on record

Corporate actions, results dates and filings will appear here once ingested.

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

10 announcementsExport CSV

30 Sept 2026, 6:15 pmAGM/EGM

Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

AGM PDF

29 Sept 2026, 5:17 pmAGM/EGM

Shareholder Meeting / Postal Ballot-Outcome of AGM

AGM PDF

28 Sept 2026, 4:24 pmCompany Update

Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Commencement Of Commercial Operations Of CT Scan Facility At Faridabad, Haryana

General PDF

4 Sept 2026, 12:53 pmOthers

Reg. 34 (1) Annual Report.

Reg. 34 (1) Annual Report PDF

2 Sept 2026, 1:14 pmCompany Update

Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication PDF

1 Sept 2026, 2:39 pmCompany Update

Web-Link To Access The Annual Report-2025-26

General PDF

1 Sept 2026, 2:29 pmAGM/EGM

Notice Of 22Nd Annual General Meeting (AGM) Of The Company For The Financial Year 2025-26

AGM PDF

1 Sept 2026, 2:24 pmOthers

Reg. 34 (1) Annual Report.

Reg. 34 (1) Annual Report PDF

Date	Category	Subject	Filing
30 Sept 2026, 6:15 pm	AGM/EGM AGM	Shareholder Meeting / Postal Ballot-Scrutinizer''s Report	PDF
29 Sept 2026, 5:17 pm	AGM/EGM AGM	Shareholder Meeting / Postal Ballot-Outcome of AGM

Loading announcements…

Star Imaging And Path Lab Ltd

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Return on equity

Ratios

Ratio timeline

Shareholding

Quarterly record

Board and management

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Events

No events on record

Announcements

Not in the F&O segment

Ratio timeline

Quarterly record

Board and management

No fund holdings on record

No events on record

Announcements

Offer and rights documents

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Return on equity